论文部分内容阅读
AIM: To study if the angiotensin Ⅱ receptor blockers (ARB) losartan counteracts pancreatic hyperenzymemiaas measured 24 h after endoscopic retrograde cholan-giopancreatography (ERCP).METHODS: A triple-blind and placebo-controlled ran-domized clinical tria